English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Natural Killer (NK) cell effector functions are dependent on phosphorylation of the mitogen-activated protein kinases (MAPK) pathway to produce an effective immune response for the clearance of target cells infected with viruses, bacteria or malignantly transformed cells. Intracellular signals activating NK cell cytokine production and cytotoxic activity are propagated through protein phosphorylation of MAPKs including MEK1/2, ERK1/2, p38 and JNK. Reduced NK cell cytotoxic activity is consistently reported in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) patients and intracellular signalling by MAPK in NK cells remains to be investigated. Therefore, the purpose of this paper was to investigate MAPK downstream signalling molecules in NK cell phenotypes from CFS/ME patients.    Methods  Flow cytometric protocols were used to measure phosphorylation of the MAPK pathway in CD56 bright CD16 dim/−  and CD56 dim CD16 +  NK cells following stimulation with K562 tumour cells or phorbol-12-myristate-13-acetate plus ionomycin. NK cell cytotoxic activity, degranulation, lytic proteins and cytokine production were also measured as markers for CD56 bright CD16 dim/−  and CD56 dim CD16 +  NK cell function using flow cytometric protocols.    Results  CFS/ME patients (n = 14) had a significant decrease in ERK1/2 in CD56 dim CD16 +  NK cells compared to the non-fatigued controls (n = 11) after incubation with K562 cells. CD56 bright CD16 dim/−  NK cells from CFS/ME patients had a significant increase in MEK1/2 and p38 following incubation with K562 cells.    Conclusions  This is the first study to report significant differences in MAPK intracellular signalling molecules in CD56 dim CD16 +  and CD56 bright CD16 dim/−  NK cells from CFS/ME patients. The current results highlight the importance of intracellular signalling through the MAPK pathway for synergistic effector function of CD56 dim CD16 +  and CD56 bright CD16 dim/−  NK cells to ensure efficient clearance of target cells. In CFS/ME patients, dysfunctional MAPK signalling may contribute to reduced NK cell cytotoxic activity.    Electronic supplementary material  The online version of this article (doi:10.1186/s12967-016-0859-z) contains supplementary material, which is available to authorized users.

journal of translational medicine

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56dimCD16+ and CD56brightCD16dim/− natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients